Australia markets closed

Vaxart, Inc. (VXRT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
8.14-0.16 (-1.93%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close8.30
Open8.28
Bid8.03 x 4000
Ask8.10 x 900
Day's range7.88 - 8.31
52-week range3.50 - 24.90
Volume4,452,761
Avg. volume19,999,746
Market cap995.262M
Beta (5Y monthly)0.39
PE ratio (TTM)N/A
EPS (TTM)-0.46
Earnings date04 Aug 2021 - 09 Aug 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend date09 Nov 2012
1y target est13.40
  • Why Shares of Vaxart Jumped 31.2% in the First Half of 2021
    Motley Fool

    Why Shares of Vaxart Jumped 31.2% in the First Half of 2021

    Shares of Vaxart (NASDAQ: VXRT) jumped 31.2% through the first half of 2021, according to data from S&P Global Market Intelligence. Over the period, the stock rose as much as 300% and fell as low as 11% below where it began the year. Investors began the year with a positive outlook for the company's proposed tablet-based COVID-19 vaccine, VXA-CoV2-1.

  • Why Coronavirus Stocks Are Zooming Higher Today
    Motley Fool

    Why Coronavirus Stocks Are Zooming Higher Today

    The surge in cases and deaths could significantly ramp up demand for these companies' existing and pipeline products.

  • 3 Small-Cap Stocks With 158% to 329% Upside, According to Wall Street
    Motley Fool

    3 Small-Cap Stocks With 158% to 329% Upside, According to Wall Street

    Despite the stock market hitting seemingly one new high after another since the year began, Wall Street still sees value in equities. Based on the highest Wall Street price target for each of the following small-cap stocks, implied upside ranging from 158% to as much as 329% may await. The first tiny tot that Wall Street appears to be really excited about is clinical-stage biotech stock Vaxart (NASDAQ: VXRT).